title: LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
abstract: Tricyclic antidepressants exert their pharmacological effect-inhibiting the reuptake of serotonin, norepinephrine, and dopamine-by directly blocking neurotransmitter transporters (SERT, NET, and DAT, respectively) in the presynaptic membrane. The drug-binding site and the mechanism of this inhibition are poorly understood. We determined the crystal structure at 2.9 angstroms of the bacterial leucine transporter (LeuT), a homolog of SERT, NET, and DAT, in complex with leucine and the antidepressant desipramine. Desipramine binds at the inner end of the extracellular cavity of the transporter and is held in place by a hairpin loop and by a salt bridge. This binding site is separated from the leucine-binding site by the extracellular gate of the transporter. By directly locking the gate, desipramine prevents conformational changes and blocks substrate transport. Mutagenesis experiments on human SERT and DAT indicate that both the desipramine-binding site and its inhibition mechanism are probably conserved in the human neurotransmitter transporters.
authors: Kimmel Center for Biology and Medicine at the Skirball Institute of Biomolecular Medicine and Department of Cell Biology, New York University School of Medicine, 540 First Avenue, New York, NY 10016, USA.
authors: Zheng
authors: Z
authors: Zhou
authors: Juan
authors: J
authors: Zhen
authors: Nathan K
authors: NK
authors: Karpowich
authors: Regina M
authors: RM
authors: Goetz
authors: Christopher J
authors: CJ
authors: Law
authors: Maarten E A
authors: ME
authors: Reith
authors: Da-Neng
authors: DN
authors: Wang
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000737:chemistry / Q000378:metabolism*; D001426:Bacterial Proteins / Q000737:chemistry / Q000378:metabolism*; D001665:Binding Sites; D029742:Caenorhabditis elegans Proteins / Q000737:chemistry / Q000378:metabolism; D002460:Cell Line; D017124:Conserved Sequence; D018360:Crystallography, X-Ray; D003891:Desipramine / Q000737:chemistry / Q000378:metabolism*; D004298:Dopamine / Q000737:chemistry / Q000378:metabolism; D018765:Dopamine Uptake Inhibitors / Q000737:chemistry / Q000378:metabolism; D029721:Drosophila Proteins / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D007930:Leucine / Q000737:chemistry / Q000378:metabolism; D008958:Models, Molecular; D008969:Molecular Sequence Data; D014179:Neurotransmitter Uptake Inhibitors / Q000737:chemistry / Q000378:metabolism*; D009638:Norepinephrine / Q000737:chemistry / Q000378:metabolism; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D050480:Plasma Membrane Neurotransmitter Transport Proteins / Q000737:chemistry / Q000378:metabolism*; D011485:Protein Binding; D011487:Protein Conformation; D017386:Sequence Homology, Amino Acid; D012701:Serotonin / Q000737:chemistry / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000737:chemistry / Q000378:metabolism
chemical_list: D000929:Antidepressive Agents, Tricyclic; D001426:Bacterial Proteins; D029742:Caenorhabditis elegans Proteins; D003891:Desipramine; D004298:Dopamine; D018765:Dopamine Uptake Inhibitors; D029721:Drosophila Proteins; D007930:Leucine; D014179:Neurotransmitter Uptake Inhibitors; D009638:Norepinephrine; D050484:Norepinephrine Plasma Membrane Transport Proteins; D050480:Plasma Membrane Neurotransmitter Transport Proteins; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
references: J Psychopharmacol. 1998;12(2):115-21
references: 9694022
references: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3603-8
references: 17360689
references: Science. 2000 Mar 17;287(5460):1960-4
references: 10720314
references: Prog Drug Res. 2000;54:59-119
references: 10857386
references: J Clin Psychiatry. 2000;61 Suppl 10:5-15
references: 10910012
references: Microbiology. 2000 Aug;146 ( Pt 8):1775-95
references: 10931885
references: Mol Pharmacol. 2001 Jan;59(1):83-95
references: 11125028
references: J Biol Chem. 2001 Mar 16;276(11):8254-60
references: 11092898
references: Nat Rev Neurosci. 2003 Jan;4(1):13-25
references: 12511858
references: Annu Rev Neurosci. 1993;16:73-93
references: 8096377
references: J Neurosci. 1997 Nov 1;17(21):8451-8
references: 9334417
references: Mol Pharmacol. 1998 Oct;54(4):601-9
references: 9765501
references: J Neurochem. 1998 Nov;71(5):1785-803
references: 9798903
references: J Pharmacol Exp Ther. 1999 May;289(2):877-85
references: 10215666
references: Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9459-64
references: 10449714
references: Cell. 1999 Sep 3;98(5):551-4
references: 10490094
references: Nature. 1961 Oct 14;192:172-3
references: 13906919
references: J Chromatogr A. 2005 Mar 11;1068(1):99-105
references: 15844547
references: Physiology (Bethesda). 2005 Aug;20:225-31
references: 16024510
references: Nature. 2005 Sep 8;437(7056):215-23
references: 16041361
references: Br J Pharmacol. 2006 Jan;147 Suppl 1:S82-8
references: 16402124
references: J Neurochem. 2006 Sep;98(5):1531-40
references: 16923164
references: Nature. 2007 Jan 25;445(7126):387-93
references: 17230192
references: Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12761-6
references: 17652169